Tag: FDA approval
30-Month Stay: How Litigation Delays Generic Drug Approval
Dec, 11 2025
The 30-month stay under the Hatch-Waxman Act lets brand drug companies delay generic approval by filing patent lawsuits. This legal tool, meant to protect innovation, often extends drug monopolies by years-costing patients billions.
Read Article→
online pharmacy
side effects
generic drugs
medication safety
dosage
counterfeit drugs
medication side effects
benefits
pharmacy alternatives
alternatives
family support
Parkinson's disease
motor symptoms
blood sugar control
warfarin
chronic kidney disease
anticoagulant safety
patent litigation
Hatch-Waxman Act
generic substitution